189 related articles for article (PubMed ID: 23844592)
1. Possible influence of mammographic density on local and locoregional recurrence of breast cancer.
Eriksson L; Czene K; Rosenberg L; Humphreys K; Hall P
Breast Cancer Res; 2013; 15(4):R56. PubMed ID: 23844592
[TBL] [Abstract][Full Text] [Related]
2. High mammographic breast density predicts locoregional recurrence after modified radical mastectomy for invasive breast cancer: a case-control study.
Huang YS; Chen JL; Huang CS; Kuo SH; Jaw FS; Tseng YH; Ko WC; Chang YC
Breast Cancer Res; 2016 Dec; 18(1):120. PubMed ID: 27906044
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort.
Maskarinec G; Pagano IS; Little MA; Conroy SM; Park SY; Kolonel LN
Breast Cancer Res; 2013 Jan; 15(1):R7. PubMed ID: 23339436
[TBL] [Abstract][Full Text] [Related]
4. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
[TBL] [Abstract][Full Text] [Related]
5. Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival.
Lång K; Sturesdotter L; Bengtsson Y; Larsson AM; Sartor H
Breast; 2024 Jun; 75():103736. PubMed ID: 38663074
[TBL] [Abstract][Full Text] [Related]
6. Mammographic density and survival in interval breast cancers.
Eriksson L; Czene K; Rosenberg LU; Törnberg S; Humphreys K; Hall P
Breast Cancer Res; 2013 Jun; 15(3):R48. PubMed ID: 23786804
[TBL] [Abstract][Full Text] [Related]
7. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery.
Cil T; Fishell E; Hanna W; Sun P; Rawlinson E; Narod SA; McCready DR
Cancer; 2009 Dec; 115(24):5780-7. PubMed ID: 19902459
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
9. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer.
Park CC; Rembert J; Chew K; Moore D; Kerlikowske K
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):75-9. PubMed ID: 18692323
[TBL] [Abstract][Full Text] [Related]
10. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract][Full Text] [Related]
11. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer.
Sun X; Gierach GL; Sandhu R; Williams T; Midkiff BR; Lissowska J; Wesolowska E; Boyd NF; Johnson NB; Figueroa JD; Sherman ME; Troester MA
Clin Cancer Res; 2013 Sep; 19(18):4972-4982. PubMed ID: 23918601
[TBL] [Abstract][Full Text] [Related]
12. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
Brand JS; Czene K; Shepherd JA; Leifland K; Heddson B; Sundbom A; Eriksson M; Li J; Humphreys K; Hall P
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1764-72. PubMed ID: 25012995
[TBL] [Abstract][Full Text] [Related]
13. Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study.
Sandberg ME; Li J; Hall P; Hartman M; dos-Santos-Silva I; Humphreys K; Czene K
Breast Cancer Res; 2013; 15(4):R57. PubMed ID: 23876209
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
[TBL] [Abstract][Full Text] [Related]
15. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.
Bertrand KA; Rosner B; Eliassen AH; Hankinson SE; Rexrode KM; Willett W; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(2):479-87. PubMed ID: 25543181
[TBL] [Abstract][Full Text] [Related]
16. Stage 0 to stage III breast cancer in young women.
Gajdos C; Tartter PI; Bleiweiss IJ; Bodian C; Brower ST
J Am Coll Surg; 2000 May; 190(5):523-9. PubMed ID: 10801018
[TBL] [Abstract][Full Text] [Related]
17. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients.
Ko KL; Shin IS; You JY; Jung SY; Ro J; Lee ES
Breast Cancer Res Treat; 2013 Dec; 142(3):559-67. PubMed ID: 24233999
[TBL] [Abstract][Full Text] [Related]
19. Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.
van Nes JG; Beex LV; Seynaeve C; Putter H; Sramek A; Lardenoije S; Duijm-de Carpentier M; Van Rongen I; Nortier JW; Zonderland HM; van de Velde CJ
Acta Oncol; 2015 Mar; 54(3):349-60. PubMed ID: 25383451
[TBL] [Abstract][Full Text] [Related]
20. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.
Li J; Humphreys K; Eriksson L; Edgren G; Czene K; Hall P
J Clin Oncol; 2013 Jun; 31(18):2249-56. PubMed ID: 23610119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
